Loading clinical trials...
Loading clinical trials...
A Phase I Study of Sorafenib and RAD001 in Patients With Metastatic Renal Cell Carcinoma
Conditions
Interventions
RAD001 and Sorafenib
Locations
1
United States
University of California, San Francisco
San Francisco, California, United States
Start Date
October 1, 2006
Primary Completion Date
December 1, 2013
Completion Date
March 1, 2014
Last Updated
August 18, 2014
NCT07485114
NCT06391099
NCT05738694
NCT07227402
NCT06349642
NCT07300241
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions